JP2024522200A5 - - Google Patents
Info
- Publication number
- JP2024522200A5 JP2024522200A5 JP2023576067A JP2023576067A JP2024522200A5 JP 2024522200 A5 JP2024522200 A5 JP 2024522200A5 JP 2023576067 A JP2023576067 A JP 2023576067A JP 2023576067 A JP2023576067 A JP 2023576067A JP 2024522200 A5 JP2024522200 A5 JP 2024522200A5
- Authority
- JP
- Japan
- Prior art keywords
- derivatives
- group
- precursor according
- following
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102021114711.5A DE102021114711B4 (de) | 2021-06-08 | 2021-06-08 | Trislinker-konjugierte dimere Markierungsvorläufer und daraus abgeleitete Radiotracer |
| DE102021114711.5 | 2021-06-08 | ||
| PCT/EP2022/065440 WO2022258637A1 (de) | 2021-06-08 | 2022-06-07 | Trislinker-konjugierte dimere markierungsvorläufer und daraus abgeleitete radiotracer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024522200A JP2024522200A (ja) | 2024-06-11 |
| JP2024522200A5 true JP2024522200A5 (enExample) | 2025-01-20 |
Family
ID=82258261
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023576067A Pending JP2024522200A (ja) | 2021-06-08 | 2022-06-07 | トリスリンカー結合二量体化標識前駆体およびそれに由来する放射性トレーサー |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250235566A1 (enExample) |
| EP (1) | EP4351663A1 (enExample) |
| JP (1) | JP2024522200A (enExample) |
| KR (1) | KR20240019301A (enExample) |
| CN (1) | CN117642190A (enExample) |
| AU (1) | AU2022288744A1 (enExample) |
| BR (1) | BR112023023149A2 (enExample) |
| CA (1) | CA3222226A1 (enExample) |
| DE (1) | DE102021114711B4 (enExample) |
| WO (1) | WO2022258637A1 (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3248367A1 (en) * | 2022-01-14 | 2023-07-20 | Provincial Health Services Authority | Radiolabeled compounds for imaging fibroblast-activating protein (FAP) and treating FAP-related disorders |
| WO2023222558A1 (en) | 2022-05-14 | 2023-11-23 | Zounek Alexis Nikolai | Precursor and theranostic radiotracer with improved tumor retention |
| DE102022116009A1 (de) * | 2022-06-28 | 2023-12-28 | Positron Precision GmbH | Fibroblasten-Aktivierungsprotein adressierender Präkursor und Radiotracer |
| CN115947775B (zh) * | 2023-03-13 | 2023-06-09 | 北京先通国际医药科技股份有限公司 | 一种制备化合物（i）的方法和化合物（i）及其用途 |
| CN117304125A (zh) * | 2023-09-12 | 2023-12-29 | 北京师范大学 | 靶向PSMA的EuK二聚体化合物及其药用盐和应用 |
| WO2025063849A2 (en) * | 2023-09-21 | 2025-03-27 | Erasmus University Medical Center Rotterdam | Dimeric fap targeting agents |
| WO2025087229A1 (zh) * | 2023-10-27 | 2025-05-01 | 四川科伦博泰生物医药股份有限公司 | 一类喹啉结构的配体化合物及其放射性或非放射性标记物以及应用 |
| WO2025125335A1 (en) | 2023-12-13 | 2025-06-19 | Radiovaxx Gmbh | Cytotoxic or radiopharmaceutical compound with sulfur fluoride exchange group |
| CN120136958A (zh) * | 2023-12-13 | 2025-06-13 | 无锡诺宇医药科技有限公司 | Fap靶向放射性药物 |
| WO2025125621A1 (en) | 2023-12-14 | 2025-06-19 | Radiovaxx Gmbh | Cancer-associated protein-targeted strong or covalently binding precursor compounds and radiotracers |
| WO2025146433A1 (en) | 2024-01-05 | 2025-07-10 | Radiovaxx Gmbh | Precursor and theranostic radiotracer with prolonged tumor retention |
| TW202535358A (zh) * | 2024-01-11 | 2025-09-16 | 大陸商上海復星醫藥產業發展有限公司 | 一種ｆａｐ結合化合物、金屬錯合物及其用途 |
| CN118271393B (zh) * | 2024-05-31 | 2024-09-03 | 中国药科大学 | 一种靶向fap的二聚化合物及其探针和应用 |
| EP4696686A1 (en) * | 2024-08-15 | 2026-02-18 | Tetrakit Technologies ApS | Fapi theranostic compounds assembled with tetrazine ligation |
| CN119060093B (zh) * | 2024-08-26 | 2025-09-05 | 广州医科大学附属第一医院（广州呼吸中心） | 一种靶向成纤维细胞激活蛋白的抑制剂类放射性探针及其制备方法和应用 |
| CN119060094B (zh) * | 2024-08-26 | 2025-09-05 | 广州医科大学附属第一医院（广州呼吸中心） | 一种靶向成纤维细胞激活蛋白的抑制剂类放射性探针及其制备方法和应用 |
| CN118955353A (zh) * | 2024-10-14 | 2024-11-15 | 南京恒远科技开发有限公司 | 一种(s)-4,4-二氟-1-甘氨酰吡咯烷-2-氰基的合成方法 |
| CN119679977B (zh) * | 2024-12-16 | 2025-09-05 | 山东第一医科大学附属肿瘤医院(山东省肿瘤防治研究院、山东省肿瘤医院) | 一种Al18F示踪剂一体化冻干粉的制备方法、试剂盒及其应用 |
| CN119409613B (zh) * | 2025-01-03 | 2025-04-11 | 南京恒远科技开发有限公司 | (s)-[2-(2-氰基-4,4-二氟吡咯烷-1-基)-2-氧代-乙基]氨基甲酸叔丁酯的合成方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3456700A1 (en) | 2013-10-18 | 2019-03-20 | Deutsches Krebsforschungszentrum | Labeled inhibitors of prostate specific membrane antigen (psma), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer |
| DE102018126558A1 (de) * | 2018-10-24 | 2020-04-30 | Helmholtz-Zentrum Dresden - Rossendorf E.V. | Markierungsvorläufer mit Quadratsäure-Kopplung |
| US11167048B2 (en) * | 2018-12-14 | 2021-11-09 | The Curators Of The University Of Missouri | Dual targeting ligand for cancer diagnosis and treatment |
| CN114502528B (zh) * | 2019-09-20 | 2024-09-06 | 墨尔本大学 | 成像和治疗组合物 |
| DE102021101216A1 (de) * | 2021-01-21 | 2022-07-21 | Johannes Gutenberg-Universität Mainz, Körperschaft des öffentlichen Rechts | Markierungsvorläufer und Radiotracer zur nuklearmedizinischen Diagnose und Therapie von Prostatakrebs induzierten Knochenmetastasen |
| CN113880810B (zh) * | 2021-09-24 | 2023-02-28 | 厦门大学 | 一种核素标记的配合物及其制备方法和应用 |
-
2021
- 2021-06-08 DE DE102021114711.5A patent/DE102021114711B4/de active Active
-
2022
- 2022-06-07 WO PCT/EP2022/065440 patent/WO2022258637A1/de not_active Ceased
- 2022-06-07 BR BR112023023149A patent/BR112023023149A2/pt unknown
- 2022-06-07 JP JP2023576067A patent/JP2024522200A/ja active Pending
- 2022-06-07 AU AU2022288744A patent/AU2022288744A1/en active Pending
- 2022-06-07 EP EP22734235.9A patent/EP4351663A1/de active Pending
- 2022-06-07 KR KR1020247000764A patent/KR20240019301A/ko active Pending
- 2022-06-07 US US18/567,891 patent/US20250235566A1/en active Pending
- 2022-06-07 CN CN202280040063.2A patent/CN117642190A/zh active Pending
- 2022-06-07 CA CA3222226A patent/CA3222226A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024522200A5 (enExample) | ||
| US5739323A (en) | Carboxamide modified polyamine chelators and radioactive complexes thereof for conjugation to antibodies | |
| US5342604A (en) | Complexes possessing ortho ligating functionality | |
| US5696239A (en) | Conjugates possessing ortho ligating functionality and complexes thereof | |
| JP2022509220A5 (ja) | 腫瘍抗原標的化剤、医薬組成物、癌診断薬又は癌治療薬、ｉｎ ｖｉｔｒｏ法、及びその化合物 | |
| JP2014506240A5 (enExample) | ||
| RU2011116223A (ru) | Селективные ингибиторы сепразы | |
| EP0444038B1 (en) | Conjugates for bone imaging and bone cancer therapy | |
| HK1006632B (en) | Carboxamide modified polyamine chelators and radioactive complexes and conjugates | |
| US20240100201A1 (en) | Labeling precursors and radiotracers for nuclear medicine diagnosis and therapy of prostate cancer-induced bone metastases | |
| EP0367223B1 (en) | Chelants possessing ortho ligating functionality and complexes thereof | |
| AU2023228308A1 (en) | Precursor markers and radiotracers with three or more targeting vectors for theranostics used in nuclear medicine | |
| CN116194155A (zh) | 用于前列腺癌放射疗法和成像的靶向psma的基于脲的配体 | |
| JP2024505374A (ja) | デュアルモード放射性トレーサーおよびその療法 | |
| US5869651A (en) | Hydrazide derivatives of polyamides and their medical use as chelating agents | |
| JP2024529307A5 (enExample) | ||
| HK1007555B (en) | Chelants possessing ortho ligating functionality and complexes thereof | |
| HK1007554B (en) | Chelants possessing ortho ligating functionality and complexes thereof | |
| AU2021252191B2 (en) | Pharmaceutical formulations | |
| EP0755385B1 (en) | Chelant compounds | |
| IL305134A (en) | Dual mode radio and medical tracker | |
| JP2024517971A5 (enExample) | ||
| KR0153501B1 (ko) | 오르토 결합 작용기를 갖는 킬란트 및 그의 착물 | |
| HK40113686A (zh) | 用於核医学治疗诊断的具有三个或更多个靶向载体的标志物前体和放射性示踪剂 | |
| JP6209643B2 (ja) | 親骨性薬剤 |